Anchorage Capital Group Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ginkgo Bioworks
DNA
|
+$817M |
| 2 |
Ardagh Metal Packaging
AMBP
|
+$27.3M |
| 3 |
ZY
Zymergen Inc. Common Stock
ZY
|
+$24.6M |
| 4 |
Enact Holdings
ACT
|
+$2.12M |
| 5 |
AMBP.WS
Ardagh Metal Packaging Warrants
AMBP.WS
|
+$2.07M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SentinelOne
S
|
+$29.8M |
| 2 |
GRSV
Gores Holdings V, Inc.
GRSV
|
+$25.3M |
| 3 |
EXE
Expand Energy Corp
EXE
|
+$7.46M |
| 4 |
FYBR
Frontier Communications
FYBR
|
+$7.05M |
| 5 |
GDP
Goodrich Petroleum Corporation Common Stock
GDP
|
+$4.73M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.6% |
| 2 | Communication Services | 6.05% |
| 3 | Energy | 1.02% |
| 4 | Consumer Discretionary | 0.68% |
| 5 | Technology | 0.37% |
Similar funds
Anchorage Capital Group's Q3 2021 Portfolio in Review
As of Q3 2021, Anchorage Capital Group held 33 positions worth $3.86B, up 204% from $1.27B the previous quarter. Its ten largest holdings account for 96% of the portfolio.
Anchorage Capital Group deployed $2.22B of net new capital in Q3 2021, opening 10 new positions and adding to 1 existing holding. Its largest new stake was Ginkgo Bioworks: 1,678,784 shares worth $778M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 0% a quarter earlier, followed by Communication Services and Energy.
On the sell side, the largest reduction was Expand Energy Corp, an estimated $7.46M trimmed.
- Anchorage Capital Group's largest Q3 2021 buy was Ginkgo Bioworks: 1,678,784 shares worth $778M.
- Anchorage Capital Group's biggest Q3 2021 reduction was Expand Energy Corp, cutting an estimated $7.46M.
- Anchorage Capital Group fully exited SentinelOne in Q3 2021, selling an estimated $29.8M.
- Anchorage Capital Group's ten largest holdings make up 96% of its $3.86B portfolio in Q3 2021.
- Anchorage Capital Group opened 10 new positions and closed 10 in Q3 2021.
- Anchorage Capital Group's portfolio value rose 204% quarter-over-quarter to $3.86B.
Based on Anchorage Capital Group's 13F filing for Q3 2021, filed 15 Nov 2021.